The company has invested heavily in R&D past couple of years and is able to grow the revenue on new approvals . There is strength of revenue growth on YoY & QoQ basis . This March we expect YoY to show good growth but QoQ to remain flat.
May 3rd, 2018
Debt /Equity: 1.18x
Mutual Fund Holding Since Last Quarter : SAME
FII Holding Since Last Quarter : UP
New Investor : Rakesh R Jhunjhunwala : 1.26%
The company has received many approval in past 6 months which are showing in revenue growth , we believe this would drive the company profitability higher and Rupee depreciation would help the exports support.
Recommendation : BUY
Buying Price Limit Till : Rs. 850
Portfolio Allocation : 2%